Teijin Pharma Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 20,000
Employees
  • Investments
  • 4

Teijin Pharma General Information

Description

Manufacturer of pharmaceutical and home healthcare products created to prevent bone and joint, respiratory, and cardiovascular and metabolic diseases. The company provides pharmaceutical drugs, sonic accelerated fracture healing system, oxygen concentrator and airway pressure device, enabling patients to have an improved quality of life through antihyperuricemic treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Kasumigaseki Common Gate West Tower, 2-1
  • Kasumigaseki 3-chome, Chiyoda-ku
  • Tokyo, 100-8585
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Teijin Pharma Executive Team (1)

Name Title Board Seat Contact Info
Taiichi Machida General Manager
To view Teijin Pharma’s complete executive team members history, request access »

Teijin Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teijin Pharma Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000 05-Jun-2014 000000000 00000000 Pharmaceuticals
000000 00000000 02-Apr-2013 000000000 00000000 Pharmaceuticals
000000 000000 0000 08-Jan-2009 000000000000000000 Industrial Chemicals
Associated Healthcare Systems 02-Jan-2008 Merger/Acquisition Medical Supplies
To view Teijin Pharma’s complete investments and acquisitions history, request access »